MedPath

TERCONAZOLE

TERCONAZOLE VAGINAL CREAM 0.8%3-Day Regimen

Approved
Approval ID

472e7b07-83fc-4857-9cc0-50e6aa03f10d

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Apr 28, 2011

Manufacturers
FDA

Rebel Distributors Corp

DUNS: 118802834

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

terconazole

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code21695-933
Application NumberNDA019964
Product Classification
M
Marketing Category
C73594
G
Generic Name
terconazole
Product Specifications
Route of AdministrationVAGINAL
Effective DateDecember 11, 2009
FDA Product Classification

INGREDIENTS (9)

CETYL ALCOHOLInactive
Code: 936JST6JCN
Classification: IACT
TERCONAZOLEActive
Quantity: 8 mg in 1 g
Code: 0KJ2VE664U
Classification: ACTIM
BUTYLATED HYDROXYANISOLEInactive
Code: REK4960K2U
Classification: IACT
POLYSORBATE 60Inactive
Code: CAL22UVI4M
Classification: IACT
ISOPROPYL MYRISTATEInactive
Code: 0RE8K4LNJS
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
POLYSORBATE 80Inactive
Code: 6OZP39ZG8H
Classification: IACT
PROPYLENE GLYCOLInactive
Code: 6DC9Q167V3
Classification: IACT
STEARYL ALCOHOLInactive
Code: 2KR89I4H1Y
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

TERCONAZOLE - FDA Drug Approval Details